The Gynecologic Cancer Program provides diagnosis and treatment using advanced technologies and the latest, research-based treatments. We offer:
- Minimally invasive surgery when possible.
- Fertility-sparing surgery and referral to Reproductive Endocrinology for assisted reproductive technologies such as oocyte retrieval and embryo storage for women desiring future pregnancy.
- Chemotherapy including intraperitoneal chemotherapy. Intraperitoneal chemotherapy is the advanced standard of care for ovarian, fallopian tube, and primary peritoneal cancers. Instead of through the veins or in a pill, intraperitoneal chemotherapy is placed directly into the abdominal cavity to "bathe" the area where the tumor was removed, providing greater exposure to the cancer-killing drugs.
- Hormonal therapy.
- Advanced radiotherapy including high-dose rate brachytherapy.
- Genetic testing and risk assessment through our Familial Cancer Program for patients with a strong family history of cancer.
- Clinical trials. As a member of the Gynecologic Oncology Group (GOG), we offer new treatment being developed in clinical trials. GOG is a National Cancer Institute-sponsored organization promoting excellence in the quality and integrity of clinical and basic scientific research in the field of gynecologic malignancies.
We recommend the following National Cancer Institute (NCI) links as good sources for information about gynecologic cancer: